HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Chunmei Wu Selected Research

yttrium chloride

1/2022Yttrium chloride-induced cytotoxicity and DNA damage response via ROS generation and inhibition of Nrf2/PPARĪ³ pathways in H9c2 cardiomyocytes.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Chunmei Wu Research Topics

Disease

2Lupus Nephritis
11/2022 - 01/2020
2Rheumatoid Arthritis
11/2022 - 01/2020
2Stomach Neoplasms (Stomach Cancer)
05/2022 - 10/2015
2Seizures (Absence Seizure)
12/2021 - 01/2020
2Infections
12/2021 - 01/2010
2Stroke (Strokes)
01/2021 - 01/2019
2Ischemic Stroke
01/2021 - 01/2019
1Interstitial Lung Diseases (Interstitial Lung Disease)
11/2022
1Proteinuria
11/2022
1Neoplasm Metastasis (Metastasis)
05/2022
1Lymphatic Metastasis
05/2022
1Cardiotoxicity
01/2022
1Autoimmune Diseases of the Nervous System
01/2022
1Prodromal Symptoms
01/2022
1Rib Fractures (Rib Fracture)
12/2021
1Pain (Aches)
12/2021
1Cerebral Infarction
01/2021
1Vascular Dementia (Subcortical Arteriosclerotic Encephalopathy)
10/2020
1Epilepsy (Aura)
01/2020
1Nausea
01/2020
1Back Pain (Backache)
01/2020
1Anemia
01/2020
1COVID-19
01/2020
1Tics (Tic)
01/2020
1Gastrointestinal Neoplasms (Gastrointestinal Cancer)
01/2020
1Fatigue
01/2020
1Breast Neoplasms (Breast Cancer)
04/2019
1Systemic Lupus Erythematosus (Libman-Sacks Disease)
01/2019
1Leukemia
09/2015

Drug/Important Bio-Agent (IBA)

2Cadherins (E-Cadherin)IBA
05/2022 - 04/2019
2Pharmaceutical PreparationsIBA
12/2021 - 01/2020
2AcidsIBA
01/2021 - 01/2020
1Serum AlbuminIBA
11/2022
1IFIH1 Interferon-Induced HelicaseIBA
11/2022
1Azathioprine (Imuran)FDA LinkGeneric
11/2022
1Immunosuppressive Agents (Immunosuppressants)IBA
11/2022
1CreatinineIBA
11/2022
1Leflunomide (Arava)FDA LinkGeneric
11/2022
1Mycophenolic Acid (Cellcept)FDA LinkGeneric
11/2022
1CalreticulinIBA
05/2022
1yttrium chlorideIBA
01/2022
1Blood Glucose (Blood Sugar)IBA
01/2022
1Tricarboxylic AcidsIBA
12/2021
1Proteins (Proteins, Gene)FDA Link
12/2021
1Analgesics (Analgesic Drugs)IBA
12/2021
1N-Methylaspartate (NMDA)IBA
01/2021
1N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA
01/2021
16-chloro-2-(1-piperazinyl)pyrazine (CPP)IBA
01/2021
1Donepezil (Aricept)FDA LinkGeneric
10/2020
1Haloperidol (Haldol)FDA LinkGeneric
01/2020
1Anticonvulsants (Antiepileptic Drugs)IBA
01/2020
1iguratimodIBA
01/2020
1N- (1- (cyclohexylmethyl)piperidin- 4- yl)- 2- (4- isopropyl- 1,4- diazepan- 1- yl)- 6- methoxy- 7- (3- (piperidin- 1- yl)propoxy)quinazolin- 4- amineIBA
04/2019
1Interferon Type IIBA
01/2019
1Actin Depolymerizing Factors (Cofilins)IBA
01/2019
1AutoantibodiesIBA
01/2019
1CoffeeFDA Link
10/2015
1Retinoic Acid Receptors (Retinoic Acid Receptor)IBA
09/2015
1RNA (Ribonucleic Acid)IBA
01/2010

Therapy/Procedure

4Therapeutics
11/2022 - 01/2020
2Moxibustion
01/2021 - 01/2019
1Critical Care (Surgical Intensive Care)
01/2022
1Length of Stay
12/2021
1Catheters
12/2021
1Analgesia
12/2021
1Drug Therapy (Chemotherapy)
01/2020
1Salvage Therapy
01/2020